ATLAS / Macro Radar / Reporting / SYRE

Spyre Therapeutics, Inc. (SYRE) reporting calendar

Spyre Therapeutics, Inc. files periodic reports with the SEC as SYRE on Nasdaq. Atlas tracks 41 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
27 Jul 2026 – 18 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
5 May 2026
Reports on record
41

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open SYRE market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20265 May 202635 days0001636282-26-000050
10-K31 Dec 202519 Feb 202650 days0001636282-26-000020
10-Q30 Sep 20254 Nov 202535 days0001636282-25-000102
10-Q30 Jun 20255 Aug 202536 days0001636282-25-000089
10-Q31 Mar 20258 May 202538 days0001636282-25-000049
10-K31 Dec 202427 Feb 202558 days0001636282-25-000020
10-Q30 Sep 20247 Nov 202438 days0001636282-24-000083
10-Q30 Jun 20247 Aug 202438 days0001636282-24-000051
10-Q31 Mar 20249 May 202439 days0001636282-24-000037
10-K31 Dec 202329 Feb 202460 days0001636282-24-000005
10-Q30 Sep 20239 Nov 202340 days0001636282-23-000018
10-Q30 Jun 202311 Aug 202342 days0000950170-23-041590
10-Q31 Mar 202311 May 202341 days0000950170-23-020825
10-K31 Dec 20222 Mar 202361 days0000950170-23-005705
10-Q30 Sep 20223 Nov 202234 days0000950170-22-021529
10-Q30 Jun 20224 Aug 202235 days0001564590-22-027895
10-Q31 Mar 20225 May 202235 days0001564590-22-018006
10-K31 Dec 20218 Mar 202267 days0001564590-22-008995
10-Q30 Sep 20214 Nov 202135 days0001564590-21-054228
10-Q30 Jun 20215 Aug 202136 days0001564590-21-041216
10-Q31 Mar 202110 May 202140 days0001564590-21-025791
10-K31 Dec 202018 Mar 202177 days0001564590-21-014021
10-Q30 Sep 20205 Nov 202036 days0001564590-20-050906
10-Q30 Jun 202010 Aug 202041 days0001564590-20-038651
10-Q31 Mar 20207 May 202037 days0001564590-20-022403
10-K31 Dec 201924 Feb 202055 days0001564590-20-005888
10-Q30 Sep 20196 Nov 201937 days0001564590-19-040692
10-Q30 Jun 20196 Aug 201937 days0001564590-19-028999
10-Q31 Mar 20197 May 201937 days0001564590-19-016211
10-K31 Dec 20187 Mar 201966 days0001564590-19-006771
10-Q30 Sep 20188 Nov 201839 days0001564590-18-028293
10-Q30 Jun 20189 Aug 201840 days0001564590-18-020760
10-Q31 Mar 20188 May 201838 days0001564590-18-011484
10-K31 Dec 201713 Mar 201872 days0001564590-18-005404
10-Q30 Sep 20177 Nov 201738 days0001564590-17-022228
10-Q30 Jun 20179 Aug 201740 days0001564590-17-016937
10-Q31 Mar 20179 May 201739 days0001564590-17-009615
10-K31 Dec 201623 Mar 201782 days0001564590-17-005137
10-Q30 Sep 20169 Nov 201640 days0001564590-16-028480
10-Q30 Jun 20169 Aug 201640 days0001564590-16-023459

Source: SEC EDGAR company submissions for CIK 0001636282. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.